(1–3)-β-D-glucan levels in candidiasis infections in the critically ill neonate

References

• Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110:285–291.
   PubMed Web of Science ®Google Scholar
• Benjamin DK Jr, Poole C, Steinbach WJ, Rowen JL, Walsh TJ. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics 2003;112:634–640.
   PubMed Web of Science ®Google Scholar
• Friedman S, Richardson SE, Jacobs SE, O’Brien K. Systemic Candida infection in extremely low birth weight infants: short term morbidity and long term neurodevelopmental outcome. Pediatr Infect Dis J 2000;19:499–504.
   PubMed Web of Science ®Google Scholar
• Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, Higgins RD; National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004;292:2357–2365.
   PubMed Web of Science ®Google Scholar
• Kaufman D. Fungal infection in the very low birthweight infant. Curr Opin Infect Dis 2004;17:253–259.
   PubMed Web of Science ®Google Scholar
• Baley JE, Kliegman RM, Boxerbaum B, Fanaroff AA. Fungal colonization in the very low birth weight infant. Pediatrics 1986;78:225–232.
   PubMed Web of Science ®Google Scholar
• Manzoni P, Farina D, Leonessa M, d’Oulx EA, Galletto P, Mostert M, Miniero R, Gomirato G. Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics 2006;118:2359–2364.
   PubMed Web of Science ®Google Scholar
• Feja KN, Wu F, Roberts K, Loughrey M, Nesin M, Larson E, Della-Latta P, et al. Risk factors for candidemia in critically ill infants: a matched case-control study. J Pediatr 2005;147:156–161.
   PubMed Web of Science ®Google Scholar
• Arendrup MC, Fisher BT, Zaoutis TE. Invasive fungal infections in the paediatric and neonatal population: diagnostics and management issues. Clin Microbiol Infect 2009;15:613–624.
   PubMed Web of Science ®Google Scholar
• Ellepola AN, Morrison CJ. Laboratory diagnosis of invasive candidiasis. J Microbiol 2005;43 Spec No:65–84.
   PubMed Web of Science ®Google Scholar
• Manzoni P, Arisio R, Mostert M, Leonessa M, Farina D, Latino MA, Gomirato G. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study. Pediatrics 2006;117:e22–e32.
   PubMed Web of Science ®Google Scholar
• Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ, Ketchum PA, et al. β-d-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004;39:199–205.
   PubMed Web of Science ®Google Scholar
• Persat F, Ranque S, Derouin F, Michel-Nguyen A, Picot S, Sulahian A. Contribution of the (1–>3)-β-d-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2008;46:1009–1013.
   PubMed Web of Science ®Google Scholar
• Senn L, Robinson JO, Schmidt S, Knaup M, Asahi N, Satomura S, Matsuura S, et al. 1,3-β-d-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 2008;46:878–885.
   PubMed Web of Science ®Google Scholar
• Mularoni A, Furfaro E, Faraci M, Franceschi A, Mezzano P, Bandettini R, Viscoli C, Castagnola E. High Levels of β-d-glucan in immunocompromised children with proven invasive fungal disease. Clin Vaccine Immunol 2010;17:882–883.
   PubMed Web of Science ®Google Scholar
• Clerihew L, Lamagni TL, Brocklehurst P, McGuire W. Invasive fungal infection in very low birthweight infants: national prospective surveillance study. Arch Dis Child Fetal Neonatal Ed 2006;91:F188–F192.
   PubMed Web of Science ®Google Scholar
• Kaufman DA. Neonatal Candidiasis: clinical manifestations, management, and prevention strategies. J Pediatr 2010;156:S53–67.
   Web of Science ®Google Scholar
• Bendel C. Candidiasis. In: Remington JS, editor. Infectious diseases of the fetus and newborn infant. 6th edition. Philadelphia: Elsevier Saunders; 2006. pp 1107–1128.
   Google Scholar
• Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL. Evaluation of a (1→3)-β-d-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2005;43:5957–5962.
   PubMed Web of Science ®Google Scholar
• Pasqualotto AC, Sukiennik TC. β-glucan in the diagnosis of invasive fungal disease. Clin Infect Dis 2008;47:292–293; author reply 3–4.
   PubMed Web of Science ®Google Scholar
• Smith PB, Benjamin DK Jr, Alexander BD, Johnson MD, Finkelman MA, Steinbach WJ. Quantification of 1,3-β-d-glucan levels in children: preliminary data for diagnostic use of the β-glucan assay in a pediatric setting. Clin Vaccine Immunol 2007;14:924–925.
   PubMed Web of Science ®Google Scholar
• Mokaddas E, Burhamah MH, Khan ZU, Ahmad S. Levels of (1→3)--d-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida species. BMC Infect Dis 2010;10:292.
   PubMed Web of Science ®Google Scholar
• Montagna MT, Coretti C, Lovero G, De Giglio O, Montagna O, Laforgia N, Santoro N, Caggiano G. Diagnostic performance of 1→3-β-d-glucan in neonatal and pediatric patients with Candidemia. Int J Mol Sci 2011;12:5871–5877.
   PubMed Web of Science ®Google Scholar
• Kaufman DA, Gurka MJ, Hazen KC, Boyle R, Robinson M, Grossman LB. Patterns of fungal colonization in preterm infants weighing less than 1000 grams at birth. Pediatr Infect Dis J 2006;25:733–737.
   PubMed Web of Science ®Google Scholar
• Benjamin DK Jr, Ross K, McKinney RE Jr, Benjamin DK, Auten R, Fisher RG. When to suspect fungal infection in neonates: a clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics 2000;106:712–718.
   PubMed Web of Science ®Google Scholar
• Metan G, Nedret Koc A, Agkus C, Kaynar LG, Alp E, Eser B. Can bacteraemia lead to false positive results in 1,3-β-d-glucan test? Analysis of 83 bacteraemia episodes in high-risk patients for invasive fungal infections. Rev Iberoam Micol 2012;29:169–171.
   PubMed Web of Science ®Google Scholar
• Albert O, Toubas D, Strady C, Cousson J, Delmas C, Vernet V, Villena I. Reactivity of (1→3)-β-d-glucan assay in bacterial bloodstream infections. Eur J Clin Microbiol Infect Dis 2011;30:1453–1460.
   PubMed Web of Science ®Google Scholar
• Mikulska M, Furfaro E, Del Bono V, Gualandi F, Van Lint MT, Miletich F, Bacigalupo A, Viscoli C. Persistence of a positive (1,3)-β-d-glucan test after clearance of candidemia in hematopoietic stem cell transplant recipients. Clin Vaccine Immunol 2011;18:518–519.
   PubMedGoogle Scholar
• Berenguer J, Buck M, Witebsky F, Stock F, Pizzo PA, Walsh TJ. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. Diagn Microbiol Infect Dis 1993;17:103–109.
   PubMed Web of Science ®Google Scholar